SS

Shiladitya Sengupta

Active Director Director DIN 01837274
DIN 01837274 First appointment Apr 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Apr 2008
Shareholding value •••• Premium profile

About Shiladitya Sengupta

Data last updated:

Shiladitya Sengupta is a Director at Vyome Therapeutics Limited (since 2017), Director at Invictus Oncology Private Limited (since 2011) and Director at India Innovation Research Center (since 2011), and holds 2 more current directorships. The companies operate in Pharma, Travel and Hospitality and Life Sciences. The 5 current companies with reported revenue have a combined latest revenue of ₹6.24 Cr; the largest is Vyome Therapeutics Limited at ₹3.35 Cr (FY 2025). Earlier, Shiladitya Sengupta was a Director at Mitra Life Sciences India Private Limited (from 2008).

DIN 01837274
Primary Designation Director
Industry Pharma
First Appointment 23 Apr 2008
Oldest Company Age 18 yrs
Largest company Vyome Therapeutics Limited · ₹3.35 Cr (FY 2025)
Combined revenue ₹6.24 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vyome Therapeutics Limited U73100GJ2017PLC098900
Director30 Aug 20172017₹3.35 Cr (FY 2025)Active
Invictus Oncology Private Limited U24232DL2011PTC217394
Director11 Apr 20112011₹2.86 Cr (FY 2025)Active
India Innovation Research Center U93000KA2011NPL061831
Director26 Dec 20112011₹1.9 Lakh (FY 2025)Active
Vyome Biosciences Private Limited U33110GJ2010PTC099141
Director19 Aug 20102010₹40,161 (FY 2025)Active
Akamara Biomedicine Private Limited U73100DL2017PTC322917
Director30 Aug 20172017₹9,100 (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Apr 20082008Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Invictus Oncology Private Limited
Vyome Biosciences Private Limited
Akamara Biomedicine Private Limited
Vyome Therapeutics Limited
Premium access

Shareholding and investment profile for Shiladitya Sengupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shiladitya Sengupta

Shiladitya Sengupta currently holds 5 directorships: Vyome Therapeutics Limited (Director, since 30 Aug 2017, revenue ₹3.35 Cr (FY 2025)); Invictus Oncology Private Limited (Director, since 11 Apr 2011, revenue ₹2.86 Cr (FY 2025)); India Innovation Research Center (Director, since 26 Dec 2011, revenue ₹1.9 Lakh (FY 2025)); Vyome Biosciences Private Limited (Director, since 19 Aug 2010, revenue ₹40,161 (FY 2025)); Akamara Biomedicine Private Limited (Director, since 30 Aug 2017, revenue ₹9,100 (FY 2024)).

Shiladitya Sengupta was first appointed on 23 Apr 2008 as Director at Mitra Life Sciences India Private Limited. The most recent appointment on record is 30 Aug 2017 at Akamara Biomedicine Private Limited.

The 5 current companies of Shiladitya Sengupta that report revenue have a combined latest revenue of ₹6.24 Cr: Vyome Therapeutics Limited ₹3.35 Cr (FY 2025); Invictus Oncology Private Limited ₹2.86 Cr (FY 2025); India Innovation Research Center ₹1.9 Lakh (FY 2025); Vyome Biosciences Private Limited ₹40,161 (FY 2025); Akamara Biomedicine Private Limited ₹9,100 (FY 2024).

Shiladitya Sengupta held 1 earlier board appointment: Mitra Life Sciences India Private Limited (Director, from 23 Apr 2008).

The current boards of Shiladitya Sengupta's companies include Raghunath Anant Mashelkar (Vyome Therapeutics Limited), Ranjana Kumar (Vyome Therapeutics Limited), Sivaram Swaminathan (Vyome Therapeutics Limited), Venkateswarlu Nelabhotla (Vyome Therapeutics Limited), Jasmin Rambhai Patel (Invictus Oncology Private Limited), Rajeev Mantri (Invictus Oncology Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available